Nepstad, I.; Reikvam, H.; Brenner, A.K.; Bruserud, Ø.; Hatfield, K.J.
Resistance to the Antiproliferative In Vitro Effect of PI3K-Akt-mTOR Inhibition in Primary Human Acute Myeloid Leukemia Cells Is Associated with Altered Cell Metabolism. Int. J. Mol. Sci. 2018, 19, 382.
https://doi.org/10.3390/ijms19020382
AMA Style
Nepstad I, Reikvam H, Brenner AK, Bruserud Ø, Hatfield KJ.
Resistance to the Antiproliferative In Vitro Effect of PI3K-Akt-mTOR Inhibition in Primary Human Acute Myeloid Leukemia Cells Is Associated with Altered Cell Metabolism. International Journal of Molecular Sciences. 2018; 19(2):382.
https://doi.org/10.3390/ijms19020382
Chicago/Turabian Style
Nepstad, Ina, Håkon Reikvam, Annette K. Brenner, Øystein Bruserud, and Kimberley J. Hatfield.
2018. "Resistance to the Antiproliferative In Vitro Effect of PI3K-Akt-mTOR Inhibition in Primary Human Acute Myeloid Leukemia Cells Is Associated with Altered Cell Metabolism" International Journal of Molecular Sciences 19, no. 2: 382.
https://doi.org/10.3390/ijms19020382
APA Style
Nepstad, I., Reikvam, H., Brenner, A. K., Bruserud, Ø., & Hatfield, K. J.
(2018). Resistance to the Antiproliferative In Vitro Effect of PI3K-Akt-mTOR Inhibition in Primary Human Acute Myeloid Leukemia Cells Is Associated with Altered Cell Metabolism. International Journal of Molecular Sciences, 19(2), 382.
https://doi.org/10.3390/ijms19020382